We are live on !
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.5B
Turnover
9.58%
1-Year Est. Return
31.38%
This Quarter Est. Return
+1.36%
1 Year Est. Return
+31.38%
3 Year Est. Return
+126.98%
5 Year Est. Return
+155.3%
10 Year Est. Return
+569.87%
AUM
$69.5B
AUM Growth
+$369M
(+0.53%)
Cap. Flow
+$545M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
48.49%
Holding
1,973
New
60
Increased
600
Reduced
1,180
Closed
129
Avg Time Held
6.7
years
Top 10 Avg Time Held
5.8
years
Top 20 Avg Time Held
5.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$574M |
| 2 |
NVIDIA
NVDA
|
+$259M |
| 3 |
Broadcom
AVGO
|
+$97.8M |
| 4 |
Micron Technology
MU
|
+$83.1M |
| 5 |
Albemarle
ALB
|
+$73.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$492M |
| 2 |
General Dynamics
GD
|
+$220M |
| 3 |
Gilead Sciences
GILD
|
+$194M |
| 4 |
Genuine Parts
GPC
|
+$189M |
| 5 |
Electronic Arts
EA
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.38% |
| 2 | Miscellaneous | 26.4% |
| 3 | Industrials | 7.03% |
| 4 | Consumer Staples | 6.28% |
| 5 | Consumer Discretionary | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
HealthEquity
HQY
$8.45B
| $1.21M | ﹤0.01% |
13,722
-725
| -5% | -$71K |
2016 Q4
39 quarters
|
|
727
Kymera Therapeutics
KYMR
$11.9B
| $1.2M | ﹤0.01% |
10,747
-153
| -1% | -$17.5K |
2023 Q4
11 quarters
|
|
728
Praxis Precision Medicines
PRAX
$9.3B
| $1.2M | ﹤0.01% |
4,124
-84
| -2% | -$27.8K |
2025 Q3
4 quarters
|
|
729
Fox Class B
FOX
$25.5B
| $1.19M | ﹤0.01% |
21,049
-633
| -3% | -$35.2K |
2019 Q1
30 quarters
|
|
730
Medpace
MEDP
$18.8B
| $1.17M | ﹤0.01% |
1,871
+1
| +0.1% | +$586 |
2017 Q4
35 quarters
|
|
731
Alkermes
ALKS
$7.76B
| $1.17M | ﹤0.01% |
28,814
-559
| -2% | -$27.2K |
2013 Q2
53 quarters
|
|
732
Jackson Financial
JXN
$8.95B
| $1.17M | ﹤0.01% |
9,028
-451
| -5% | -$57.8K |
2021 Q4
19 quarters
|
|
733
DELISTED
Roku
ROKU
| $1.16M | ﹤0.01% |
7,606
-209
| -3% | -$31.4K |
2026 Q2
1 quarter
|
|
734
Commercial Metals
CMC
$7.1B
| $1.14M | ﹤0.01% |
18,370
-781
| -4% | -$52.6K |
2013 Q2
53 quarters
|
|
735
Global E Online
GLBE
$7.14B
| $1.14M | ﹤0.01% |
28,713
-12,782
| -31% | -$497K |
2021 Q3
20 quarters
|
|
736
SM Energy
SM
$6.84B
| $1.13M | ﹤0.01% |
33,384
-1,221
| -4% | -$40.9K |
2020 Q2
25 quarters
|
|
737
Spyre Therapeutics
SYRE
$10.4B
| $1.13M | ﹤0.01% |
12,653
+54
| +0.4% | +$5.19K |
2024 Q4
7 quarters
|
|
738
Hut 8
HUT
$6.84B
| $1.13M | ﹤0.01% |
13,077
-559
| -4% | -$52.9K |
2024 Q3
8 quarters
|
|
739
Ryman Hospitality Properties
RHP
$9.34B
| $1.11M | ﹤0.01% |
9,315
+352
| +4% | +$44.3K |
2013 Q2
53 quarters
|
|
740
Qualys
QLYS
$7B
| $1.11M | ﹤0.01% |
5,940
-356
| -6% | -$59.9K |
2017 Q4
35 quarters
|
|
741
TG Therapeutics
TGTX
$9.7B
| $1.11M | ﹤0.01% |
19,920
-681
| -3% | -$36.9K |
2020 Q2
25 quarters
|
|
742
Axcelis
ACLS
$3.32B
| $1.11M | ﹤0.01% |
8,467
-5,534
| -40% | -$708K |
2020 Q4
23 quarters
|
|
743
Nutanix
NTNX
$16.2B
| $1.11M | ﹤0.01% |
15,733
-981
| -6% | -$61.6K |
2023 Q2
13 quarters
|
|
744
EnerSys
ENS
$5.47B
| $1.1M | ﹤0.01% |
5,995
-337
| -5% | -$63.8K |
2013 Q2
53 quarters
|
|
745
Ormat Technologies
ORA
$5.82B
| $1.09M | ﹤0.01% |
11,961
-428
| -3% | -$44.2K |
2020 Q2
25 quarters
|
|
746
Jazz Pharmaceuticals
JAZZ
$15.6B
| $1.09M | ﹤0.01% |
4,718
+185
| +4% | +$45.7K |
2013 Q2
53 quarters
|
|
747
MaxLinear
MXL
$5.07B
| $1.09M | ﹤0.01% |
12,095
-335
| -3% | -$25.4K |
2020 Q2
25 quarters
|
|
748
Fluor
FLR
$6.45B
| $1.09M | ﹤0.01% |
22,693
-1,637
| -7% | -$85.3K |
2020 Q2
25 quarters
|
|
749
Ultra Clean Holdings
UCTT
$2.2B
| $1.08M | ﹤0.01% |
13,362
-9,495
| -42% | -$792K |
2022 Q4
15 quarters
|
|
750
Ligand Pharmaceuticals
LGND
$6.28B
| $1.08M | ﹤0.01% |
3,444
-76
| -2% | -$22.5K |
2013 Q2
53 quarters
|
|
Similar funds
ProShare Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, ProShare Advisors held 1,973 positions worth $69.5B, up 0.53% from $69.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ProShare Advisors's Q3 2026 filing shows 60 new, 600 increased, 1,180 reduced and 129 closed positions. Its largest new stake was SpaceX: 4,144,774 shares worth $625M. The largest sale was ProShares GENIUS Money Market ETF, an estimated $492M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Miscellaneous and Industrials.
- ProShare Advisors's largest Q3 2026 buy was SpaceX: 4,144,774 shares worth $625M.
- ProShare Advisors added most to NVIDIA in Q3 2026, an estimated $259M increase.
- ProShare Advisors's biggest Q3 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $492M.
- ProShare Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $55.7M.
- ProShare Advisors's ten largest holdings make up 48% of its $69.5B portfolio in Q3 2026.
- ProShare Advisors opened 60 new positions and closed 129 in Q3 2026.
- ProShare Advisors's portfolio value rose 0.53% quarter-over-quarter to $69.5B.
Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.